Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun;11(2):351-366.
doi: 10.1016/j.path.2018.02.007. Epub 2018 Mar 26.

Hepatic Adenomas: Classification, Controversies, and Consensus

Affiliations
Review

Hepatic Adenomas: Classification, Controversies, and Consensus

Michael Torbenson. Surg Pathol Clin. .

Abstract

Rapid advances in molecular and anatomic pathology have greatly improved our understanding of hepatocellular adenomas. Principle among them is a clinically relevant, histology-based classification that identifies hepatic adenomas at greatest risk for malignant transformation. This new classification system has led to general consensus on the major subtypes of hepatic adenomas. However, controversy remains regarding how to incorporate less common types of hepatic adenomas into the classification system and how to incorporate adenoma subtyping into clinical care. This article provides an in-depth review of how adenomas are classified, with a focus on the current rationale, the consensus, and controversies.

Keywords: Androgen adenoma; Beta-catenin activated adenoma; Classification; HNF1 alpha inactivated adenoma; Hepatic adenoma; Heptaocellular adenoma; Histology; Inflammatory adenoma; Malignant transformation; Myxoid adenoma; Pathology; Pigmented adenoma.

Similar articles

See all similar articles

MeSH terms

LinkOut - more resources

Feedback